eyeBrain Medical
Newport Beach, US · Founded 2012 · Delaware corporation · 2 known investors
Founders & leadership
DC
Davis CorleyExecutive
JA
J. Andy CorleyNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$126.3M disclosed across 6 rounds · 2014–2022
▶$67.6MraisedSep 2022 · 31 investors · BiotechnologyRule 506(b)
▶$67.6MraisedSep 2022 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom FinziDirector
- Das NarayandasDirector
- Danny PeralesExecutive Officer
- William LinkDirector
- J. Andy CorleyDirector
- Akhilesh PathipatiDirector
- Aric PlumleyExecutive Officer
- Steve KirbyDirector
- Davis CorleyExecutive Officer, Director
- Pierre BertrandExecutive Officer
- Eric BednarskiDirector
- Offering amount
- $67.6M
- Amount sold
- $67.6M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.7MraisedJun 2022 · 27 investors · BiotechnologyRule 506(b)
▶$14.7MraisedJun 2022 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Das NarayandasDirector
- J. Andy CorleyDirector
- Pierre BertrandExecutive Officer
- Danny PeralesExecutive Officer
- Davis CorleyDirector
- Tom FinziDirector
- William LinkDirector
- Steve KirbyDirector
- Offering amount
- $15M
- Amount sold
- $14.7M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.8MraisedMar 2020 · 24 investors · BiotechnologyRule 506(b)
▶$23.8MraisedMar 2020 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William LinkDirector
- Steve T. KirbyDirector
- Tom FrinziDirector
- Daniel PeralesExecutive Officer
- Dean ButlerDirector
- J. Andy CorleyExecutive Officer, Director
- Davis CorleyExecutive Officer, Director
- John TullisDirector
- Offering amount
- $24M
- Amount sold
- $23.8M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.1MraisedDec 2017 · 35 investors · BiotechnologyRule 506(b)
▶$13.1MraisedDec 2017 · 35 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom FrinziDirector
- William LinkDirector
- Dean ButlerDirector
- J. Andy CorleyExecutive Officer, Director
- Steve T. KirbyDirector
- Davis CorleyExecutive Officer, Director
- Daniel PeralesExecutive Officer
- Offering amount
- $14M
- Amount sold
- $13.1M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$6MraisedDec 2015 · 21 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2015 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Davis CorleyExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1MraisedNov 2014 · 1 investors · Other TechnologyRule 506(b)
▶$1MraisedNov 2014 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Davis CorleyExecutive Officer, Promoter
- J. Andy CorleyExecutive Officer, Director, Promoter
- Jeffrey KrallPromoter
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are eyeBrain Medical's investors?
- eyeBrain Medical's investors include MVM Life Science Partners, Versant Venture AIV Holdings.
- How much funding has eyeBrain Medical raised?
- eyeBrain Medical has disclosed $126.3M raised across 6 rounds.
- Where is eyeBrain Medical headquartered?
- eyeBrain Medical is headquartered in Newport Beach, US.